Ultra‐high pressure LC for astaxanthin determination in shrimp by‐products and active food packaging

Nowadays, there is increasing interest in natural antioxidants from food by‐products. Astaxanthin is a potent antioxidant and one of the major carotenoids in crustaceans and salmonids. An ultra‐high pressure liquid chromatographic method was developed and validated for the determination of astaxanthin in shrimp by‐products, and its migration from new packaging materials to food simulants was also studied. The method uses an UPLC® BEH guard‐column (2.1 × 5 mm, 1.7 µm particle size) and an UPLC® BEH analytical column (2.1 × 50 mm, 1.7 µm particle size). Chromatographic separation was achieved using a programmed gradient mobile phase consisting of (A) acetonitrile–methanol (containing 0.05 m ammonium acetate)–dichloromethane (75:20:5, v/v/v) and (B) ultrapure water. This method was evaluated with respect to validation parameters such as linearity, precision, limit of detection, limit of quantification and recovery. Low‐density polyethylene films were prepared with different amounts of the lipid fraction of fermented shrimp waste by extrusion, and migration was evaluated into food simulants (isooctane and ethanol 95%, v/v). Migration was not detected under the tested conditions. Copyright © 2012 John Wiley & Sons, Ltd.     

Biological N Removal from Wastes Generated from Amine-Based CO2 Capture: Case Monoethanolamine

Large-scale amine-based CO₂ capture will generate waste containing large amounts of ammonia, in addition to contaminants such as the actual amine as well as degradation products thereof. Monoethanolamine (MEA) has been a dominant amine applied so far in this context. This study reveals how biological N removal can be achieved even in systems heavily contaminated by MEA in post- as well as pre-denitrification treatment systems, elucidating the rate-limiting factors of nitrification as well as aerobic and denitrifying biodegradation of MEA. The hydrolysis of MEA to ammonia readily occurred both in post- and pre-denitrification treatment systems with a hydraulic retention time of 7 h. MEA removal was ≥99?±?1 % and total nitrogen removal 77?±?10 % in both treatment systems. This study clearly demonstrates the advantage of pre-denitrification over post-denitrification for achieving biological nitrogen removal from MEA-contaminated effluents. Besides the removal of MEA, the removal efficiency of total nitrogen as well as organic matter was high without additional carbon source supplied.     

A Ferrofluid with Surface Modified Nanoparticles for Magnetic Hyperthermia and High ROS Production

A ferrofluid with 1,2-Benzenediol-coated iron oxide nanoparticles was synthesized and physicochemically analyzed. This colloidal system was prepared following the typical co-precipitation method, and superparamagnetic nanoparticles of 13.5 nm average diameter, 34 emu/g of magnetic saturation, and 285 K of blocking temperature were obtained. Additionally, the zeta potential showed a suitable colloidal stability for cancer therapy assays and the magneto-calorimetric trails determined a high power absorption density. In addition, the oxidative capability of the ferrofluid was corroborated by performing the Fenton reaction with methylene blue (MB) dissolved in water, where the ferrofluid was suitable for producing reactive oxygen species (ROS), and surprisingly a strong degradation of MB was also observed when it was combined with H₂O₂. The intracellular ROS production was qualitatively corroborated using the HT-29 human cell line, by detecting the fluorescent rise induced in 2,7-dichlorofluorescein diacetate. In other experiments, cell metabolic activity was measured, and no toxicity was observed, even with concentrations of up to 4 mg/mL of magnetic nanoparticles (MNPs). When the cells were treated with magnetic hyperthermia, 80% of cells were dead at 43 °C using 3 mg/mL of MNPs and applying a magnetic field of 530 kHz with 20 kA/m amplitude.     

Viscoelastic characterization of TEOS sols in three different solvents when DBTL is used as polycondensation catalyst

The gelation process of TEOS sols in three different solvents using di-n-butyltin dilaurate (DBTL) as polycondensation catalyst has been investigated. Sol compositions were similar to those employed in the field of stone consolidation for the conservation of historical buildings. Three different systems were studied: TEOS in ethanol (S-EtOH) which was tested to explain gelation in protic solvents; TEOS in a mixture of methylethylketone/acetone (S-MA) to represent aprotic solvents; and TEOS in a blend of MEK/ethanol (S-ME) for comparison of a system with properties intermediate between protic and aprotic solvents. The gelation process was studied by measuring the viscoelastic behavior near the gelation point (GP). A scaling exponent (Δ) was determined for the elastic modulus, G(ω)′ and the viscous modulus, G′′(ω), which both follow the same power law, ω^Δ, at GP. The fractal dimension, df, was calculated from the scaling exponent, Δ, for each TEOS-DBTL system. For each type of solvent studied, values of Δ from 0.34 to 0.53 with df of 1.9–2.2 were obtained. The results suggest that DBTL leads to a TEOS polycondensation mechanism similar to that observed for a base-catalyst system. However, the change in df suggests that there is a significant effect of the solvent on aggregation mechanisms of the gelation process. A diffusion limited cluster–cluster aggregation mechanism (DLCCA) was observed when ethanol was used as protic solvent, while a reaction limited cluster–cluster aggregation mechanism (RLCCA) was observed for MEK/acetone (aprotic solvent).     

Textile/Metal–Organic‐Framework Composites as Self‐Detoxifying Filters for Chemical‐Warfare Agents

The current technology of air‐filtration materials for protection against highly toxic chemicals, that is, chemical‐warfare agents, is mainly based on the broad and effective adsorptive properties of hydrophobic activated carbons. However, adsorption does not prevent these materials from behaving as secondary emitters once they are contaminated. Thus, the development of efficient self‐cleaning filters is of high interest. Herein, we report how we can take advantage of the improved phosphotriesterase catalytic activity of lithium alkoxide doped zirconium(IV) metal–organic framework (MOF) materials to develop advanced self‐detoxifying adsorbents of chemical‐warfare agents containing hydrolysable P? F, P? O, and C? Cl bonds. Moreover, we also show that it is possible to integrate these materials onto textiles, thereby combining air‐permeation properties of the textiles with the self‐detoxifying properties of the MOF material.     

Stoichiometry,Association Constant,and Solvation Model of Chiral Hydroxyfuranones in the Presence of Pirkle's Alcohols

ABSTRACT

(S)-(+)-Dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanone, (R)-(-)-dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanone, (S)-(-)-dihydro-4-hydroxy-2(3H)-furanone, and (S)-(-)-5-hydroxymethyl-2(5H)-furanone in the presence of pure enantiomers of 2,2,2-trifluoro-1-(9-anthryl)ethanol were studied by ¹H NMR in deuterated chloroform solutions. Experimental Job's plots suggest that the resulting solvates are formed with one molecule of solute and one of the chiral solvating agent. From the magnitude of the association constant determined for (S)-(+)-dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanone in the presence of (R)-(-)-2,2,2-trifluoro-1-(9-anthryl)ethanol (1.26 ± 0.09 M^?1), it is inferred that the solvate is weak and cannot be isolated at 298 K. The correlation between the magnitude of induced chemical shifts, NOESY maps, and the known configuration of solutes and chiral solvating agents suggests that intermolecular hydroxyl-hydroxyl interaction is the primary interaction. Accordingly, the secondary interaction might occur between benzylic-hydrogen of the chiral solvating agent and the carbonyl- or furan ring-oxygen atoms of the solute.     

Determination of Very Slow Diffusion of Paramagnetic Ions by NMR Spectroscopy

In this paper, we propose a new method of measuring the very slow paramagnetic ion diffusion coefficient using a commercial high-resolution spectrometer. If there are distinct paramagnetic ions influencing the hydrogen nuclear magnetic relaxation time differently, their diffusion coefficients can be measured separately. A cylindrical phantom filled with Fricke xylenol gel solution and irradiated with gamma rays was used to validate the method. The Fricke xylenol gel solution was prepared with 270 Bloom porcine gelatin, the phantom was irradiated with gamma rays originated from a ⁶⁰Co source and a high-resolution 200 MHz nuclear magnetic resonance (NMR) spectrometer was used to obtain the phantom ¹H profile in the presence of a linear magnetic field gradient. By observing the temporal evolution of the phantom NMR profile, an apparent ferric ion diffusion coefficient of 0.50 μm²/ms due to ferric ions diffusion was obtained. In any medical process where the ionizing radiation is used, the dose planning and the dose delivery are the key elements for the patient safety and success of treatment. These points become even more important in modern conformal radio therapy techniques, such as stereotactic radiosurgery, where the delivered dose in a single session of treatment can be an order of magnitude higher than the regular doses of radiotherapy. Several methods have been proposed to obtain the three-dimensional (3-D) dose distribution. Recently, we proposed an alternative method for the 3-D radiation dose mapping, where the ionizing radiation modifies the local relative concentration of Fe²⁺/Fe³⁺ in a phantom containing Fricke gel and this variation is associated to the MR image intensity. The smearing of the intensity gradient is proportional to the diffusion coefficient of the Fe³⁺ and Fe²⁺ in the phantom. There are several methods for measurement of the ionic diffusion using NMR, however, they are applicable when the diffusion is not very slow.     

Recombinant drugs-on-a-chip: The usage of capillary electrophoresis and trends in miniaturized systems – A review

We present here a critical review covering conventional analytical tools of recombinant drug analysis and discuss their evolution towards miniaturized systems foreseeing a possible unique recombinant drug-on-a-chip device. Recombinant protein drugs and/or pro-drug analysis require sensitive and reproducible analytical techniques for quality control to ensure safety and efficacy of drugs according to regulatory agencies. The versatility of miniaturized systems combined with their low-cost could become a major trend in recombinant drugs and bioprocess analysis. Miniaturized systems are capable of performing conventional analytical and proteomic tasks, allowing for interfaces with other powerful techniques, such as mass spectrometry. Microdevices can be applied during the different stages of recombinant drug processing, such as gene isolation, DNA amplification, cell culture, protein expression, protein separation, and analysis. In addition, organs-on-chips have appeared as a viable alternative to testing biodrug pharmacokinetics and pharmacodynamics, demonstrating the capabilities of the miniaturized systems. The integration of individual established microfluidic operations and analytical tools in a single device is a challenge to be overcome to achieve a unique recombinant drug-on-a-chip device.